{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Candida+Systemic", "query": { "condition": "Candida Systemic" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 36, "total_pages": 4, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Candida+Systemic&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-07-22T21:12:06.375Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03604705", "title": "An Efficacy and Safety Study of APX001 in Non-Neutropenic Patients With Candidemia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Candidemia" ], "interventions": [ { "name": "APX001", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Basilea Pharmaceutica", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 21, "start_date": "2018-10-03", "completion_date": "2020-07-02", "has_results": true, "last_update_posted_date": "2025-09-16", "last_synced_at": "2026-07-22T21:12:06.375Z", "location_count": 9, "location_summary": "Birmingham, Alabama • Davis, California • Sacramento, California + 5 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Davis", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Augusta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT03604705" }, { "nct_id": "NCT02163889", "title": "Serial Therapeutic and Antifungal Monitoring Protocol", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Candidemia" ], "interventions": [], "intervention_types": [], "sponsor": "T2 Biosystems", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "95 Years", "sex": "ALL", "summary": "18 Years to 95 Years" }, "enrollment_count": 31, "start_date": "2014-09", "completion_date": "2017-04", "has_results": false, "last_update_posted_date": "2018-08-20", "last_synced_at": "2026-07-22T21:12:06.375Z", "location_count": 3, "location_summary": "Birmingham, Alabama • Pittsburgh, Pennsylvania • Providence, Rhode Island", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Pittsburgh", "state": "Pennsylvania" }, { "city": "Providence", "state": "Rhode Island" } ], "official_url": "https://clinicaltrials.gov/study/NCT02163889" }, { "nct_id": "NCT03667690", "title": "Study of Rezafungin Compared to Caspofungin in Subjects With Candidemia and/or Invasive Candidiasis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Candidemia", "Mycoses", "Fungal Infection", "Invasive Candidiases" ], "interventions": [ { "name": "Rezafungin for Injection", "type": "DRUG" }, { "name": "Caspofungin", "type": "DRUG" }, { "name": "Fluconazole", "type": "DRUG" }, { "name": "intravenous placebo", "type": "DRUG" }, { "name": "oral placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 199, "start_date": "2018-10-07", "completion_date": "2021-10-07", "has_results": true, "last_update_posted_date": "2023-01-06", "last_synced_at": "2026-07-22T21:12:06.375Z", "location_count": 19, "location_summary": "Birmingham, Alabama • Sacramento, California • Atlanta, Georgia + 16 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Sacramento", "state": "California" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Augusta", "state": "Georgia" }, { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT03667690" }, { "nct_id": "NCT02734862", "title": "CD101 Compared to Caspofungin Followed by Oral Step Down in Subjects With Candidemia and/or Invasive Candidiasis-Bridging Extension", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Candidemia", "Mycoses", "Fungal Infection", "Fungemia", "Invasive Candidiasis" ], "interventions": [ { "name": "CD101", "type": "DRUG" }, { "name": "Caspofungin", "type": "DRUG" }, { "name": "Fluconazole", "type": "DRUG" }, { "name": "intravenous placebo", "type": "DRUG" }, { "name": "oral placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 207, "start_date": "2016-07-26", "completion_date": "2019-07", "has_results": true, "last_update_posted_date": "2020-12-08", "last_synced_at": "2026-07-22T21:12:06.375Z", "location_count": 16, "location_summary": "Birmingham, Alabama • Davis, California • Miami, Florida + 12 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Davis", "state": "California" }, { "city": "Miami", "state": "Florida" }, { "city": "Augusta", "state": "Georgia" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT02734862" }, { "nct_id": "NCT00496197", "title": "Study Will Evaluate The Safety And Efficacy Of Anidulafungin In Patients With Candidemia Or Invasive Candidiasis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Candidiasis" ], "interventions": [ { "name": "Eraxis (anidulafungin)", "type": "DRUG" }, { "name": "Diflucan (fluconazole)", "type": "DRUG" }, { "name": "Vfend (voriconazole)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 282, "start_date": "2007-07", "completion_date": "2010-06", "has_results": true, "last_update_posted_date": "2011-10-03", "last_synced_at": "2026-07-22T21:12:06.375Z", "location_count": 39, "location_summary": "Birmingham, Alabama • Little Rock, Arkansas • Los Angeles, California + 25 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00496197" }, { "nct_id": "NCT01525095", "title": "Detecting Infections Rapidly and Easily for Candidemia Trial (DIRECT)", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Candidemia" ], "interventions": [], "intervention_types": [], "sponsor": "T2 Biosystems", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "95 Years", "sex": "ALL", "summary": "18 Years to 95 Years" }, "enrollment_count": 700, "start_date": "2012-01", "completion_date": "2014-03", "has_results": false, "last_update_posted_date": "2014-06-09", "last_synced_at": "2026-07-22T21:12:06.375Z", "location_count": 5, "location_summary": "Birmingham, Alabama • San Francisco, California • Lexington, Kentucky + 2 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "San Francisco", "state": "California" }, { "city": "Lexington", "state": "Kentucky" }, { "city": "Detroit", "state": "Michigan" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01525095" }, { "nct_id": "NCT01869829", "title": "PEACE: Pediatric Antifungal Comparative Effectiveness", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Pediatric Invasive Candidiasis" ], "interventions": [ { "name": "Observational antifungal therapy", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Duke University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "120 Days", "maximum_age": "18 Years", "sex": "ALL", "summary": "120 Days to 18 Years" }, "enrollment_count": 750, "start_date": "2015-01", "completion_date": "2018-04", "has_results": false, "last_update_posted_date": "2022-01-28", "last_synced_at": "2026-07-22T21:12:06.375Z", "location_count": 27, "location_summary": "Little Rock, Arkansas • Orange, California • Palo Alto, California + 24 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Orange", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01869829" }, { "nct_id": "NCT02220790", "title": "BIOPIC: Fungal Biomarkers for Diagnosis and Response to Therapy for Pediatric Candidemia", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Invasive Candidiasis" ], "interventions": [], "intervention_types": [], "sponsor": "Duke University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "120 Days", "maximum_age": "18 Years", "sex": "ALL", "summary": "120 Days to 18 Years" }, "enrollment_count": 515, "start_date": "2015-01", "completion_date": "2020-10-08", "has_results": false, "last_update_posted_date": "2022-02-28", "last_synced_at": "2026-07-22T21:12:06.375Z", "location_count": 19, "location_summary": "Little Rock, Arkansas • Orange, California • San Diego, California + 16 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Orange", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "St. Petersburg", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02220790" }, { "nct_id": "NCT00058682", "title": "Anidulafungin Versus Fluconazole in the Treatment of Candidemia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Candida", "Candidiasis" ], "interventions": [ { "name": "Anidulafungin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 248, "start_date": "2003-04", "completion_date": "2005-01", "has_results": false, "last_update_posted_date": "2008-03-04", "last_synced_at": "2026-07-22T21:12:06.375Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00058682" }, { "nct_id": "NCT03059992", "title": "Study to Evaluate the Efficacy and Safety of Ibrexafungerp in Patients With Fungal Diseases That Are Refractory to or Intolerant of Standard Antifungal Treatment", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Invasive Candidiasis", "Mucocutaneous Candidiasis", "Coccidioidomycosis", "Histoplasmosis", "Blastomycosis", "Chronic Pulmonary Aspergillosis", "Allergic Bronchopulmonary Aspergillosis", "Invasive Pulmonary Aspergillosis", "Recurrent Vulvovaginal Candidiasis", "Other Emerging Fungi" ], "interventions": [ { "name": "Ibrexafungerp", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Scynexis, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 233, "start_date": "2017-04-01", "completion_date": "2023-08-25", "has_results": true, "last_update_posted_date": "2024-11-20", "last_synced_at": "2026-07-22T21:12:06.375Z", "location_count": 20, "location_summary": "Birmingham, Alabama • Sacramento, California • San Francisco, California + 16 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Sacramento", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Augusta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT03059992" } ] }